Premature centromere division in patients with multiple endocrine neoplasia type 1

Cancer Genet Cytogenet. 1999 Mar;109(2):138-40. doi: 10.1016/s0165-4608(98)00156-3.

Abstract

Frequency of mitoses with premature centromere division (PCD) was examined in lymphocytes from subjects with multiple endocrine neoplasia type 1 (MEN 1). An increase in PCD after exposure to an alkylating agent was observed in subjects with MEN 1 who carry a heterozygous MEN1 gene mutation but not in normal controls or in affected subjects without the MEN1 gene mutation. These findings support the inclusion of MEN 1 as a chromosome instability syndrome and recognition of PCD as a manifestation of chromosome instability. Furthermore, these results suggest that the MEN1 gene product may function to maintain the integrity of DNA.

MeSH terms

  • Adult
  • Aged
  • Centromere / genetics*
  • Epoxy Compounds / pharmacology
  • Heterozygote
  • Humans
  • Lymphocytes / drug effects
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / genetics*
  • Mutation
  • Neoplasm Proteins / genetics
  • Proto-Oncogene Proteins*
  • Reference Values

Substances

  • Epoxy Compounds
  • MEN1 protein, human
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • diepoxybutane